Learn More
Invitrogen™ Phospho-MLK1/MLK2 (Thr312, Thr266) Polyclonal Antibody

Description
A suggested positive control for IHC is human brain tissue.
Specifications
Specifications
| Antigen | Phospho-MLK1/MLK2 (Thr312, Thr266) |
| Applications | Immunohistochemistry (Paraffin) |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 |
| Gene | MAP3K9 |
| Gene Accession No. | P80192, Q02779, Q3U1V8, Q66L42 |
| Gene Alias | BC028668; BC046514; E130314H24Rik; Map3k10; Map3k9; MEKK10; MEKK9; mitogen activated protein kinase kinase kinase 9; mitogen-activated protein kinase kinase kinase 10; Mitogen-activated protein kinase kinase kinase 9; Mixed lineage kinase 1; mixed lineage kinase 1 (tyr and ser/thr specificity); mixed lineage kinase 2; MKN28 derived nonreceptor_type; MKN28 derived nonreceptor_type serine/threonine kinase; MKN28 kinase; MLK1; MLK2; MST; PRKE1; protein kinase MST; serine/threonine kinase |
| Gene Symbols | MAP3K10, MAP3K9 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.